Children exposed before birth to synthetic compounds called “forever chemicals” had higher blood pressure during their teenage years, according to research published in the Journal of the American Heart Association. The study was also presented at the Society for Epidemiologic Research (SER) Conference in Boston.
Study finds word recognition is shaped by spelling-to-meaning consistency in neighbors
The architecture and processes underlying visual word recognition represent some of the most intricate systems in human cognition. The seemingly simple act of reading a word involves not only a complex interplay between cognitive layers but also relationships between the word’s spelling, phonology, and meaning.
Researchers discover protein necessary for SARS-CoV-2 to evade the body’s defenses
The human body is naturally equipped with defenses to fight off viral infections. For a virus to successfully infect it, it must first overcome these defenses. To do so, viruses have evolved specialized tools—proteins known as “virulence factors”—that help them shut down or dodge the immune system and cause disease.
Bilirubin and the brain: Jaundice-associated pigment may protect against malaria
Scientists say they have new experimental evidence of a novel role for bilirubin, a natural yellow pigment found in the body, in protecting humans from the worst effects of malaria and potentially other infectious diseases. The findings could advance the search for drugs that mimic the pigment bilirubin, or deliver it to the body to help protect people from severe forms of some infections.
Integration of psychosomatic and psychiatric diagnostic systems: Redesigning personalized treatment
Although psychosomatic medicine is regarded as a branch of psychiatry in many countries, some of its diagnostic concepts are not fully encompassed by mainstream psychiatric diagnostic systems. When these two systems are integrated, the interrelationships among various diagnoses and their associations with psychopathologies remain to be elucidated.
Enhancing ultrasound imaging: Researchers develop detachable acoustic lens for precise focus adjustment
The Korea Research Institute of Standards and Science has developed a detachable acoustic lens that allows for easy adjustment of the focal length in ultrasonic inspection equipment. Much like swapping lenses on a DSLR camera to improve image quality, this technology enables users to optimize the resolution of ultrasonic imaging systems for specific inspection tasks. The innovation is expected to significantly enhance accuracy in both medical diagnostics and industrial safety inspections.
Vitamin D can increase likelihood that breast cancer will disappear with chemotherapy
A study conducted at the Botucatu School of Medicine at São Paulo State University (FMB-UNESP) in Brazil has shown that low-dose vitamin D supplementation can increase the effectiveness of chemotherapy treatment in women with breast cancer. The results suggest that the substance could be an alternative to hard-to-access drugs that also aim to increase the response to chemotherapy.
ALS care: Global differences in life support decisions
A new study reveals striking international differences in how doctors approach the sensitive issue of tracheostomy invasive ventilation (TIV) for patients with amyotrophic lateral sclerosis (ALS). Cultural norms and health care systems appear to significantly influence physician attitudes and, consequently, patient choices regarding this life-sustaining treatment.
Holiday heart: The overindulgences during festival season that put even healthy people at risk
Festival season can be surprisingly physically demanding. Hours spent standing, walking or dancing can put extra strain on the heart, especially for those with preexisting conditions such as heart disease, high blood pressure or diabetes, explains Gosia Wamil, M.D., Ph.D., a cardiologist at Mayo Clinic Healthcare in London.
Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile
A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia (AML) showed high rates of complete remission in an early-phase clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and 11 other sites nationwide.